Concepedia

Author

Bärbel Matthey

University of Cologne

Also Known As

Bärbel Matthey, Bärbel Matthey

6

Publications

289

Citations

5

H-Index

16

Concepts

All Affiliations

University of CologneUniversity Hospital Cologne
BM

About

Bärbel Matthey is an author at University of Cologne specializing in biotechnology, protein engineering, and microbiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

136

2

Natural Sciences

1

1

38

3

Clinical Immunology

1

1

136

4

Immunology

1

1

136

5

Microbiology

1

1

38

Bärbel Matthey

×

5

Publications

289

Citations

5

H-Index

YearCitations

A Phase I study with an anti-CD30 ricin A-chain immunotoxin (Ki-4.dgA) in patients with refractory CD30+ Hodgkin's and non-Hodgkin's lymphoma.

Roland Schnell, Oliver Staak, Peter Borchmann,

PubMed

2002

136

Ki-4(scFv)–ETA′, a new recombinant anti-CD30 immunotoxin with highly specific cytotoxic activity against disseminated Hodgkin tumors in SCID mice

Stefan Barth, Michael Hühn, Bärbel Matthey,

Blood

2000

80

A new series of pET-derived vectors for high efficiency expression of Pseudomonas exotoxin-based fusion proteins

Bärbel Matthey, Andreas Engert, Alexander Klimka,

Gene

1999

38

Inhibition of metalloproteinases enhances the internalization of anti‐CD30 antibody Ki‐3 and the cytotoxic activity of Ki‐3 immunotoxin

Hinrich P. Hansen, Bärbel Matthey, Stefan Barth,

International Journal of Cancer

2001

21

Ki-4(scFv)–ETA′, a new recombinant anti-CD30 immunotoxin with highly specific cytotoxic activity against disseminated Hodgkin tumors in SCID mice

Stefan Barth, Michael Hühn, Bärbel Matthey,

Blood

2000

14

Page 1